J&J files law­suit against sev­er­al phar­ma­cies and dis­trib­u­tors over coun­ter­feit HIV med­ica­tion

John­son & John­son is on the at­tack against dis­trib­u­tors and phar­ma­cies that have al­leged­ly sold coun­ter­feit HIV med­ica­tion be­ing ad­ver­tised as their prod­uct.

The case, which was filed in the East­ern Dis­trict of New York ear­li­er this month, is against four en­ti­ties in­clud­ing Safe Chain So­lu­tions, LLC, ProPhar­ma Dis­tri­b­u­tion LLC, Scripts Whole­sale Inc. and I Care Phar­ma­cy 14, Inc.

J&J al­leges that they re­ceived a se­ries of com­plaints from pa­tients who found that their pre­scribed bot­tles of Sym­tuza, which is used to treat HIV, con­tained the wrong pills in­side the bot­tles, and that there were dif­fer­ent drugs in­stead. An in­ves­ti­ga­tion con­duct­ed by Janssen claimed that these bot­tles were coun­ter­feits, as the process con­trols at its pack­ag­ing plant make it im­pos­si­ble for gen­uine Sym­tuza bot­tles to con­tain any­thing but Sym­tuza pills.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.